Acromegaly
Acromegaly is a rare hormonal disorder that occurs when the pituitary gland produces too much growth hormone, leading to abnormal growth of bones and tissues, particularly in the hands, feet, and face.
Acromegaly: Paltusotine Treatment Study
We are studying the long-term safety and effectiveness of paltusotine for people with acromegaly. This research aims to improve treatment options for managing this condition.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a female who is non-pregnant and non-breastfeeding?
- Do you have any significant heart problems or severe kidney disease?
- Have you had any type of cancer in the past 5 years, except for treated skin cancers?
- Are you currently taking any medications that affect heart rhythm, like certain heart medications or antidepressants?
- Have you had any major health issues or hospitalizations in the past year?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Paltusotine
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Klinikum der Universitaet Muenchen AöR
Medizinische Klinik und Poliklinik IV
Munich, Germany
Evaggelismos Hospital
Endocrinology Department - Diabetes and Metabolism
Athens, Greece
General Hospital Of Athens G Gennimatas
Endocrinologist Department and Diabetes Center
Athens, Greece
Sponsor: Crinetics Pharmaceuticals Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.